InsidersTradesSigma
Track the Enumeral Biomedical Holdings, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 6 January 2016 (Attribution). Among the most active insiders: VAN NOSTRAND ROBERT L. All data is openly available.
Analysts rate Enumeral Biomedical Holdings, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Enumeral Biomedical Holdings, Inc. is a company focused on developing immunotherapy treatments for cancer. It utilizes advanced technologies to identify and develop drugs targeting the immune system.